Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association of Proton Pump Inhibitor Use With All-Cause and Cause-Specific Mortality
Chun‐Han Lo, Peiyun Ni, Yan Yan, et al.
Gastroenterology (2022) Vol. 163, Iss. 4, pp. 852-861.e2
Open Access | Times Cited: 21

Showing 21 citing articles:

Meta‐analysis: Use of proton pump inhibitors and risk of gastric cancer in patients requiring gastric acid suppression
Daniele Piovani, Andreas G. Tsantes, Holger J. Schünemann, et al.
Alimentary Pharmacology & Therapeutics (2022) Vol. 57, Iss. 6, pp. 653-665
Open Access | Times Cited: 21
Proton pump inhibitors and 1-year risk of adverse outcomes after discharge from internal medicine wards: an observational study in the REPOSI cohort
Chiara Elli, Alessio Novella, Luca Pasina
Internal and Emergency Medicine (2025)
Closed Access
Biases in Electronic Health Records Data for Generating Real-World Evidence: An Overview
Ban Al-Sahab, Alan Leviton, Tobias Loddenkemper, et al.
Journal of Healthcare Informatics Research (2023) Vol. 8, Iss. 1, pp. 121-139
Closed Access | Times Cited: 10
Gastrointestinal disorders in post-COVID syndrome. Clinical guidelines
В. Б. Гриневич, Л. Б. Лазебник, Yu. A. Kravchuk, et al.
Experimental and Clinical Gastroenterology (2023), Iss. 12, pp. 4-68
Open Access | Times Cited: 9
Proton pump inhibitor use and the risk of metachronous gastric cancer after H. pylori eradication in patients who underwent endoscopic resection for gastric neoplasms: A population‐based cohort study
Eun Jeong Gong, Hye‐Kyung Jung, Bora Lee, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 7, pp. 668-677
Open Access | Times Cited: 9
Should evidence of an autolysosomal de-acidification defect in Alzheimer and Parkinson diseases call for caution in prescribing chronic PPI and DMARD?
Sandy Giuliano, Christopher Montemagno, Marie Angela Domdom, et al.
Autophagy (2023) Vol. 19, Iss. 10, pp. 2800-2806
Open Access | Times Cited: 8
Proton pump inhibitors and gastroprotection in patients treated with antithrombotic drugs: A cardiologic point of view
Maurizio Giuseppe Abrignani, Alberto Lombardo, Annabella Braschi, et al.
World Journal of Cardiology (2023) Vol. 15, Iss. 8, pp. 375-394
Open Access | Times Cited: 7
Inhibitors of gastric acid secretion increase oxidative stress and matrix metalloproteinase-2 activity leading to vascular remodeling
Renato C. Nogueira, Jéssica M. Sanches-Lopes, Gustavo H. Oliveira‐Paula, et al.
Molecular and Cellular Biochemistry (2024) Vol. 479, Iss. 11, pp. 3141-3152
Closed Access | Times Cited: 2
Proton pump inhibitors and cancer treatments: Emerging evidence against coadministration
Jean‐Luc Raoul, Philip D. Hansten
Cancer Treatment Reviews (2024) Vol. 129, pp. 102794-102794
Closed Access | Times Cited: 2
Úlcera péptica
Isabel Laucirica, Pilar García Iglesias, Xavier Calvet
Medicina Clínica (2023) Vol. 161, Iss. 6, pp. 260-266
Closed Access | Times Cited: 6
Hyponatremia Associated with the Use of Common Antidepressants in the All of Us Research Program
Huan Mo, Yamna Channa, Tracey M. Ferrara, et al.
Clinical Pharmacology & Therapeutics (2024)
Closed Access | Times Cited: 1
Safe use of proton-pump inhibitors
Carlos Martín de Argila de Prados, Julia López-Cardona, Federico Argüelles‐Arias
Revista Española de Enfermedades Digestivas (2023) Vol. 115
Open Access | Times Cited: 3
Proton pump inhibitors associated with an increased risk of mortality in elderly: a systematic review and meta-analysis
Hyun Jin Song, Hyun‐Ju Seo, Xinyi Jiang, et al.
European Journal of Clinical Pharmacology (2023) Vol. 80, Iss. 3, pp. 367-382
Closed Access | Times Cited: 3
Navigating the risks of using concomitant antipeptic agents in light of osteoporotic concerns
Hae Won Yoo, Su Jin Hong
The Korean Journal of Internal Medicine (2024) Vol. 39, Iss. 2, pp. 201-202
Open Access
Proton Pump Inhibitor Use and Worsening Kidney Function: A Retrospective Cohort Study Including 122,606 Acid-Suppressing Users
Antonio González‐Pérez, Samuel J. Martínez‐Domínguez, Ángel Lanas, et al.
Journal of General Internal Medicine (2024)
Open Access
Risk of pneumonia associated with proton pump inhibitor use
Kenta Watanabe, Katsunori Iijima
Journal of Gastroenterology (2023) Vol. 58, Iss. 9, pp. 945-946
Closed Access | Times Cited: 1
Peptic ulcer
Isabel Laucirica, Pilar García Iglesias, Xavier Calvet
Medicina Clínica (English Edition) (2023) Vol. 161, Iss. 6, pp. 260-266
Closed Access | Times Cited: 1
Proton Pump Inhibitors and Mortality
Helge L. Waldum, Reidar Fossmark
Gastroenterology (2022) Vol. 164, Iss. 6, pp. 1021-1021
Open Access | Times Cited: 2
Reply
Chun‐Han Lo, Andrew T. Chan
Gastroenterology (2023) Vol. 164, Iss. 6, pp. 1021-1022
Open Access
PPIの功罪（PCABを含む）
Katsunori Iijima
Nihon Naika Gakkai Zasshi (2023) Vol. 112, Iss. 1, pp. 7-9
Open Access
Association of Long-term Use of Proton Pump Inhibitors with Mortality
Da Hyun Jung
Korean Journal of Gastroenterology (2022) Vol. 80, Iss. 4, pp. 203-205
Open Access
Page 1

Scroll to top